Two physicians have pleaded guilty to insider trading that helped a hedge fund that had invested in healthcare companies avoid $30 million in losses on a firm developing a drug for hepatitis C.
Docs plead guilty to insider trading
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.